Please use this identifier to cite or link to this item: http://10.9.150.37:8080/dspace//handle/atmiyauni/688
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAkbari, P.M.-
dc.contributor.authorLadva, Kartik.-
dc.contributor.authorShah, V.R.-
dc.date.accessioned2021-08-17T12:04:00Z-
dc.date.available2021-08-17T12:04:00Z-
dc.date.issued2018-04-01-
dc.identifier.citationAkbari, P. M., Ladva, K. D., & Shah, V. R. (2018). Synthesis and Biological Screening of N-(4-(6-Amino-5-cyano-4-aryl-pyridin-2-yl) phenyl) cyclopropane Carboxamide.International Journal for Research in Applied Science & Engineering Technology, 6(4), 4624-4627.en_US
dc.identifier.issn2321-9653-
dc.identifier.urihttps://www.ijraset.com/archive-detail.php?AID=71-
dc.identifier.urihttp://10.9.150.37:8080/dspace//handle/atmiyauni/688-
dc.description.abstractAbstract: Cyanopyridine derivatives shows good biological and therapeutic activities and exhibit wide range of applications in the field of pharmaceutical and agriculture. Cyanopyridine derivatives like some new N-(4-(6-Amino-5-cyano-4-aryl-pyridin-2- yl)phenyl)cyclopropane carboxamide of type (2a-l) have been prepared by the condensation of such new chalcone derivatives N- (4-(3-Aryl- acryloyl)phenyl)cyclopropane carboxamide of type (1a-l) with Malononitrile in presence of Ammonium acetate. All the prepared compounds were characterized by their spectral (I.R., 1H NMR. & Mass) data and screened for their antimicrobial activities.en_US
dc.language.isoen_USen_US
dc.publisherInternational Journal for Research in Applied Science & Engineering Technologyen_US
dc.subjectCyanopyridines, Chalcones, Malononitrile, Antimicrobial activities.en_US
dc.titleSynthesis and Biological Screening of N-(4-(6- Amino-5-cyano-4-aryl-pyridin-2-yl) phenyl) cyclopropane Carboxamideen_US
dc.typeArticleen_US
Appears in Collections:01. Journal Articles

Files in This Item:
File Description SizeFormat 
VSC_CHE_FJA_24.pdf423.09 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.